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E-mail address: c.c.paulusma@amc.uva.nl (C.C. PauP4 ATPases are integral transmembrane proteins implicated in phospholipid translocation from the
exoplasmic to the cytosolic leaﬂet of biological membranes. Our present knowledge on the cellular
physiology of P4 ATPases is mostly derived from studies in the yeast Saccharomyces cerevisiae, where
P4 ATPases play a pivotal role in the biogenesis of intracellular transport vesicles, polarized protein
transport and protein maturation. In contrast, the physiological and cellular functions of mamma-
lian P4 ATPases are largely unexplored. P4 ATPases act in concert with members of the CDC50 pro-
tein family, which are putative b-subunits for P4 ATPases. This review highlights the current status
of a slowly emerging research ﬁeld and emphasizes the contribution of P4 ATPases to the vesicle-
generating machinery.
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Lipid ﬂippases are proteins that catalyze the transport of lipid
molecules from the exoplasmic to the cytosolic leaﬂet of mem-
brane bilayers. Lipid ﬂippases are crucial for maintaining a non-
randomized distribution of phospholipids over the two hemi-leaf-
lets in many biological membranes. Already since the early 1970-
ties it is known that phospholipids are non-randomly distributed
in biological bilayers. In most eukaryotic cells, phosphatidylcholine
(PC) and (glycero)sphingolipids are enriched in the exoplasmic
leaﬂet, whereas the aminophospholipids phosphatidylserine (PS)
and phosphatidylethanolamine (PE) are largely conﬁned to the
cytosolic leaﬂet of the endomembrane system [1–3]. Furthermore,
the less abundant phospholipids, phosphatidylinositol (and deriv-
atives) and phosphatidic acid, are also concentrated in the cytosolic
leaﬂet [4–6]. An exception are the membranes of the endoplasmic
reticulum in which the phospholipids are distributed randomly
over the two leaﬂets. Phospholipids tend to equilibrate between
the two leaﬂets of a bilayer (a process termed ‘scrambling’) at very
slow rates (reviewed in [7]). However, due to extensive membrane
fusion and budding events in the intracellular trafﬁcking pathways,
phospholipid scrambling is accelerated. Scrambling is of physiolog-
ical importance for e.g. the activation of the blood coagulation,
sperm capacitation, and the engulfment of apoptotic cells and
can be accelerated by Ca2+-regulated scramblases [8,9]; However,
phospholipid randomization also interferes with membranechemical Societies. Published by E
lusma).dynamics and may impair membrane-associated protein structure
and function [10]. Thus, maintaining and dissipating the non-ran-
dom distribution of phospholipids is crucial for normal regulated
cell function, and requires the activity of proteins that are able to
catalyze the intramembranous transport phospholipids. Lipid
ﬂippases and lipid ﬂoppases are ATP-dependent proteins that are
implicated in the generation and preservation of the non-random
distribution of phospholipids (reviewed in [11,12]). Lipid ﬂoppases
transport lipids from the cytosolic to the exoplasmic leaﬂet of
bilayers, and several members of the ATP-binding cassette (ABC)
transporter protein family display such an activity [13]. The role
of ABC transporters in lipid ﬂopping will be discussed elsewhere
in this issue. In 1984, the ﬁrst ATP-dependent lipid ﬂippase activity
was identiﬁed in erythrocyte membranes [14]. In 1989, a second
ﬂippase activity was identiﬁed in Golgi-derived chromafﬁn gran-
ules from bovine adrenal glands, which would be required for
the generation of fusion-competent membrane vesicles [15]. How-
ever, the gene(s) encoding these activities, and the nature of the
protein(s) remained elusive. In 1996, the cDNA encoding the bo-
vine chromafﬁn granule ﬂippase, termed ATPaseII and presently
known as ATP8A1, was isolated [16].
2. The P4 ATPase subfamily
ATP8A1 and its Saccharomyces cerevisiae ortholog Drs2p were
identiﬁed as the ﬁrst members of the type 4 subfamily of the P-type
ATPase superfamily (abbreviated to P4 ATPase) (Fig. 1). Both pro-
teins were identiﬁed as aminophospholipid ﬂippases for their abil-
ity to translocate ﬂuorescently-labeled PS (NBD-PS) [16]. P4lsevier B.V. All rights reserved.
Fig. 1. Phylogenetic analyses of the P4 ATPase protein family of mammalian, Arabidopsis thaliana, S. cerevisiae, and C. elegans using ClustalW sequence alignment software
(http://align.genome.jp/clustalw/). The P4 ATPases are subdivided into classes, based on amino acid consensus sequences [17,110]. ALA2 is closest related to Dnf3p (class 4)
but does not contain any of the class-speciﬁc consensus sequences. Database accession numbers: C. elegans: tat-1 (NP_001022894), tat-2 (NP_001023252), tat-3
(NP_499363), tat-4 (NP_495244), tat-5 (NP_001021457), tat-6 (NP_503858); Arabidopsis thaliana: ALA1 (P98204), ALA2 (P98205), ALA3 (Q9XIE6), ALA4 (Q9LNQ4), ALA5
(Q9SGG3), ALA6 (Q9SLK6), ALA7 (Q9LVK9), ALA8 (Q9LK90), ALA9 (Q9SX33), ALA10 (Q9LI83), ALA11 (Q9SAF5), ALA12 (P57792); S. cerevisiae: Drs2p (P39524), Dnf1p (P32660),
Dnf2p (Q12675), Dnf3p (Q12674), Neo1p (P40527). Human: ATP8A1 (P70704), ATP8A2 (P98200), ATP8B1 (O43520), ATP8B2 (P98198), ATP8B3 (O60423), ATP8B4 (Q8TF62),
ATP9A (O75110), ATP9B (O43861), ATP10A (O60312), ATP10B (O94823), ATP10D (Q9P241), ATP11A (P98196), ATP11B (Q9Y2G3), ATP11C (Q8NB49). Type 2 (non-P4) ATPase
accession numbers: ATP1A1 (P05023), ATP2A1 (O14983), ATP2A2 (P16615).
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ant from the other P-type ATPase subfamilies in that they are impli-
cated in the transport of phospholipids rather than in the transport
of cations [12,17,18]. Studies in S. cerevisiae, Arabidopsis thaliana,
and Caenorhabditis elegans suggest an important role for P4 ATPases
in the biogenesis of transport vesicles in the biosynthetic and endo-
cytic pathways. In particular, the mammalian P4 ATPase subfamily
is poorly studied. However, inactivation of one member causes se-
vere human disease, while inactivation of some murine P4 ATPasessuggests roles in fertility-related disorders, insulin resistance and
obesity (reviewed in [19]). Recently, several groups have demon-
strated an important chaperone function for members of the evolu-
tionary conserved Cdc50 protein family. It is suggested that CDC50
proteins are b-subunits for P4 ATPases, analogous to the b-subunits
for other P-type ATPases such as the Na,K-ATPase, and are impor-
tant for regulation of trafﬁcking and activity of the P4 ATPase. In
this review, we will highlight the present knowledge of this slowly
emerging and very exciting family of proteins.
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Most of our present knowledge on the cellular physiology of P4
ATPases is derived from studies in the yeast S. cerevisiae. Yeast cells
express ﬁve P4 ATPases i.e. Drs2p, Dnf1p, Dnf2p, Dnf3p, and Neo1p
that are pivotal for the biogenesis of intracellular transport vesicles
in the biosynthetic and endocytic pathways (reviewed in [20]).
Drs2p is the most extensively-studied P4 ATPase. Drs2p-deﬁcient
yeast cells have a defect in late Golgi function evidenced by im-
paired formation of clathrin-coated transport vesicles at the
trans-Golgi network (TGN) and delayed posttranslational process-
ing and transport of several secretory proteins [21,22]. Drs2p shut-
tles between the TGN and early endosomes in an AP-1/clathrin-
dependent pathway [23]. Drs2p, which physically interacts with
AP-1, is not essential for coat recruitment, since in Drs2p-deﬁcient
cells both AP-1 and clathrin are normally recruited to the TGN.
However, Drs2p ATPase activity, and thus most likely the ﬂipping
of phospholipids, is essential for clathrin-coated vesicle formation
[23]. Thus, although the initial binding of the AP-1/clathrin coat
proteins does not require Drs2p activity, Drs2p-mediated lipid ﬂip-
ping possibly induces membrane curvature which facilitates the
binding of additional (coat) proteins and drives the formation of
a clathrin-coated vesicle at the TGN or endosome. There are more
indications that Drs2p contributes to the vesicle-generating
machinery. First, several studies have shown a genetic association
between Drs2p and proteins of the trafﬁcking machinery, including
ADP-ribosylation factors (recruitment of coat protein complexes),
Rab proteins (membrane docking), and proteins of the endocytic
recycling machinery [23–26]. Secondly, and in addition to a direct
physical interaction with AP-1 [23], Drs2p also interacts with the
Arf guanine nucleotide-exchange factor Gea1p [27,28], and with
the F-box protein Rcy1 (involved in recycling between endosomes
and TGN) [24]. Thirdly, using a proteomics-based approach, Puts
et al. [29] have identiﬁed nine new Drs2p-interacting proteins of
which three proteins are involved in phosphoinositide metabolism.
Phosphoinositides play a critical role in the regulation of mem-
brane/protein trafﬁcking in the biosynthetic and endocytic path-
ways, mainly via binding and activation of downstream target
proteins (reviewed in [30]). In mammalian cells, PtdIns(4)P is
essential for the recruitment of the clathrin coat protein machinery
to the TGN, and thus for the initiation of clathrin-coated vesicle
generation [31]. Recently, Natarajan et al. [28] have shown that
Drs2p needs to interact with phosphoinositides, and in particular
with PtdIns(4)P, to catalyze NBD-PS ﬂipping across isolated TGN
membranes. All these observations suggest that Drs2p-catalyzed
phospholipid ﬂipping is critical for the vesicle-generating protein
machinery at the TGN. In addition, the different subcellular distri-
butions of the newly identiﬁed Drs2p-interacting proteins (i.e. Gol-
gi apparatus (GA), ER, plasmamembrane, and vacuole) suggest that
Drs2p resides in different protein complexes within distinct traf-
ﬁcking pathways [29]. The physiological substrate for Drs2p is
presently not known. Drs2p ﬂips NBD-PS and NBD-PE (but not
NBD-PC) across isolated membranes of the TGN and of post-Golgi
secretory vesicles, suggesting that Drs2p-mediated ﬂipping is
headgroup-speciﬁc [32,33]. Drs2p-deﬁcient cells display enhanced
binding of PS-speciﬁc annexin V and are sensitive to the PS-binding
drug papuamide B, which suggests that Drs2p mediates the ﬂip-
ping of natural PS at the plasma membrane [34]. Using tempera-
ture-sensitive Drs2p mutants (Drs2p-ts), Chen et al. [34] showed
that acute inactivation of Drs2p did not result in PS exposure with-
in 4 h after inactivation. In contrast, NBD-PS translocation in iso-
lated Drs2p-ts TGN membranes was inactivated already after 1 h
[33], and already within 30 min after inactivation these mutants
displayed impaired vesicle formation at the TGN [21]. Thus, plasma
membrane exposure of PS in Drs2p-deﬁcient most likely is a con-sequence of the defect in Drs2p-mediated protein trafﬁcking to
the plasma membrane [34]. Furthermore, natural PS seems an un-
likely in vivo substrate since PS is not essential for the biogenesis of
transport vesicles at the TGN: yeast mutants that completely lack
PS synthesis are not impaired in clathrin-coated vesicle generation
at the TGN [33]. This does not exclude the possibility that PS is rel-
evant for vesicle generation; In the complete absence of PS, other,
low-afﬁnity phospholipids (e.g. PE) may substitute the contribu-
tion of PS. Reconstitution experiments of Drs2p into proteolipo-
somes again indicate that Drs2p is a ﬂippase speciﬁc for NBD-PS
[35]. The authors did not study NBD-PE ﬂipping in this system.
Less is known about the other four P4 ATPases. Dnf1p and
Dnf2p are mainly plasma membrane-associated and cycle between
early endosome and plasma membrane and early endosome and
TGN [22,36]. Dnf1p and Dnf2p double mutant cells have a defect
in the internalization step of ﬂuid-phase endocytosis (to which
Dnf2p deletion was the major contributor); this phenotype was
aggravated when also Drs2p was deleted [36]. In these triple mu-
tants, receptor-mediated endocytosis is also severely impaired. In
addition, Drs2p and Dnf1p double mutants are impaired in the
TGN-to-vacuole transport of alkaline phosphatase [22]. The endo-
cytosis defects coincide with impaired ATP-dependent and non-
endocytic uptake of NBD-PE, NBD-PC, NBD-PS, and radiolabeled
lyso-PC and lyso-PE [36–38]. Uptake of NBD-labeled sphingoid-
based lipids was not impaired, which indicates that the transloca-
tion defect is speciﬁc for glycerophospholipids [36]. Importantly,
double and triple mutants exposed small amounts of natural PE
and PS in the plasma membrane [34,36]. Although this justiﬁes
the speculation that Dnf1p and Dnf2p ﬂip glycerophospholipids
to initiate (endocytic) membrane vesiculation, the substrate spec-
iﬁcities are not known. In addition, and in contrast to Drs2p, no
Dnf1p or Dnf2p binding partners have been identiﬁed yet that con-
nect these plasma membrane P4 ATPases to the vesicle-generating
machinery.
Dnf3p predominantly localizes to the TGN and early endosomes
and, together with Drs2p, in post-Golgi secretory vesicles
[22,32,36]. Post-Golgi secretory vesicles of Drs2p-Dnf3p double
mutant cells are impaired in the NBD-PS, PE, and PC translocation
[32]. NBD-PE ﬂipping in both single mutants is still present. To-
gether with the observation that the asymmetric PE distribution
(normally present in wild-type post-Golgi secretory vesicles) is
dissipated in Drs2p-Dnf3p double mutant cells, this suggests that
PE can be the natural substrate for Drs2p and/or Dnf3p.
Neo1p is the only essential P4 ATPase in yeast. This implicates
that, in contrast to Drs2p and Dnfp1-3, there is no functional
redundancy with the other P4 ATPases in the Neo1p pathway.
Neo1p localizes to the ER and GA and is implicated in retrograde,
COPI-dependent transport between GA and ER [20,39]. Neo1p mu-
tant cells exhibit defects in secretory protein transport and protein
glycosylation in the GA, phenotypes that have suggested to be sec-
ondary to the defect in retrograde transport [39]. In another study,
Neo1p localizes to GA and endosomes [40]. In this study, Neo1p
mutant cells display defects in receptor-mediated endocytosis,
vacuolar protein sorting, and vacuole biogenesis. In contrast to
the other four P4 ATPases, there is presently no experimental data
to support a lipid ﬂippase function for Neo1p. Interestingly, the
NEO1 gene was named as such because overexpression of Neo1p
conferred resistance to neomycin [41]. At present, the relation be-
tween neomycin resistance and Neo1p expression is not clear. It is
of interest to mention that Goodyear et al. [42] recently showed
that neomycin induces PS exposure (associated with membrane
blebbing) in the apical membrane of sensory hair cells in the co-
chlea, as shown by ﬂuorescent annexin V labeling. PS scrambling
was caused by neomycin-induced PIP2 clustering which is a known
trigger for phospholipid scrambling ([42] and references therein).
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PS was rapidly endocytosed and redistributed throughout the cyto-
plasm in a myosin VI-dependent manner, the latter being a motor
protein implicated in endocytosis [43]. In this light, it is of interest
to note that deﬁciency of the mammalian P4 ATPase ATP8B1
causes hearing defects as a result of degeneration of sensory hair
cells [44] (see below).
4. P4 ATPases in Arabidopsis thaliana
Studies in the plant A. thaliana also support a role for P4 ATPases
in phospholipid ﬂipping and vesicle biogenesis. The Arabidopsis
genome encodes 12 P4 ATPases, termed ALA1-ALA12 (for amino-
phospholipid ATPase) [45,46]. Thus far, only ALA3 has been exten-
sively characterized [47]. ALA3 is an Arabidopsis ortholog of Drs2p
(42% amino acid identity) and localizes to the GA of peripheral col-
umella cells in the tips of roots and shoots. Ala3 mutant plants dis-
play impaired growth of roots and shoots, which is most likely
caused by a defect in the release of the peripheral cell layer (an
event required for normal root growth) [47]. Analogous to yeast
Drs2p mutants, Ala3-deﬁcient peripheral columella cells displayed
reduced amounts of a speciﬁc class of TGN-derived secretory ves-
icles. These vesicles contain polysaccharides and enzymes required
for cell wall breakdown and release of the peripheral cell layer.
Ala3 mutants also accumulated large vacuolar structures reminis-
cent of the GA-derived autophagosome-like vacuoles observed in
Drs2p mutants [22,48]. ALA3 expressed in yeast Drs2p/Dnf1p/
Dnf2p triple mutants stimulated plasma membrane ﬂipping of
NBD-PS, PE, and PC (but not of lyso-PLs), and reduced outer leaf-
let-exposed PS and PE [47,49]. Little is known for the other 11
ALA proteins. Ala1 is expressed in many different tissues, however
the subcellular localization of the protein is not known [45]. ALA1
expression in Drs2p mutant yeast cells complemented the defect in
plasma membrane ﬂipping of NBD-PS, which suggests a role for
ALA1 in the GA. Furthermore, ALA1 stimulated the ﬂipping of
NBD-PS and NBD-PE in reconstituted microsomes. Ala1 mutant
plants displayed impaired growth only at chilling temperatures
(612 C), however, the relation between this phenotype and a lipid
ﬂippase function for ALA1 remains to be demonstrated. ALA2 has
recently been localized to the prevacuolar compartments of tobac-
co epidermal cells; ALA2 expression in yeast Drs2p/Dnf1p/Dnf2p
triple mutants stimulated speciﬁcally NBD- and natural PS plasma
membrane ﬂipping [49].
5. P4 ATPases in C. elegans
The nematode C. elegans expresses 6 P4 ATPases, termed TAT-1–
6 (for transbilayer amphipath transporter), of which most have dif-
ferent splice variants, and of which TAT-6 is a possible pseudogene
of TAT-5 [50–52]. TAT-1 shares 40% amino acid identity with Drs2p
and is expressed in neurons, muscle, epidermis, and intestine [51].
In the intestinal epithelial cells, a GFP fusion of TAT-1 localized to
basolateral and apical membranes and to the endosomal and Golgi
system [51,53]. Studies on the role of TAT-1 are not conclusive. Ini-
tially, TAT-1 was characterized as an aminophospholipid translo-
case required for PS exposure during the early stages of
apoptosis as Tat-1 deﬁcient apoptotic cells did not expose PS
[52]. However, these ﬁndings could not be reproduced by others.
Data by Darland-Ransom et al. [53] suggested a function for TAT-
1 in the maintenance of the asymmetric distribution of PS in the
plasma membrane; Tat-1 deletion (but not tat-2 to tat-6) coincided
with annexin V detectable PS exposure in (non-apoptotic) somatic
cells and in germ cells of the gonads. Ruaud et al. [51] presented
data that suggest a role for TAT-1 in the early steps of endocytosis
in several cell types, including intestinal epithelial cells and oo-cytes, and in the biogenesis of lysosomes; Tat-1 mutants displayed
impaired endocytic uptake of ﬂuid-phase markers by the intestine
and of yolk by oocytes. Furthermore, Tat-1 mutant intestinal epi-
thelial cells were devoid of a certain class of storage granules
(the formation of which requires lysosomal protein-1 (LMP-1)),
and accumulate large LMP-1-positive pre-lysosomal vacuoles; this
latter observation suggests a defect in a late phase process in the
formation of these storage granules. Tat-1 mutant epidermal cells
accumulate large multivesicular bodies, which are intermediates
in the biosynthetic- and endocytic (recycling) machinery and in
the biogenesis of (endo)lysosomal compartments. Genetic studies
in Tat-2 mutant animals indicate a role for TAT-2 in the regulation
of post-embryonic growth of C. elegans, predominantly via its
activity in intestinal epithelial cells [54]; Tat-2 depletion over-
comes the growth inhibition observed in worms that are deprived
from monomethyl branched-chain fatty acids. However, the rela-
tion between this phenotype and intestinal TAT-2 activity is pres-
ently not known. Whereas Tat-5 is the only, ubiquitously
expressed, essential gene, Tat-1 to Tat-4 are not essential for nor-
mal growth, development, and reproduction of C. elegans [55].
Interestingly, Tat-2 and Tat-4 mutants are growth-inhibited when
deprived from exogenous sterol sources [55]. C. elegans ingests
exogenous sterols in the intestine to convert it into 7-dehydroxys-
terol, which is metabolized to an essential reproductive hormone.
It is presently not known what the contribution is of TAT-2 and
TAT-4 in sterol metabolism. Although not the most likely explana-
tion, these TAT proteins could mediate direct sterol uptake. Alter-
natively, TAT-2 and TAT-4 are important for maintaining the
asymmetric distribution of phospholipids in biological mem-
branes. Tat-2 and/or Tat-4 deﬁciency may compromise membrane
structure, which impairs the activity of (a) sterol transporter(s) in
the intestinal epithelial cells. Although both TAT proteins have
overlapping expression patterns (including the intestine), the sub-
cellular localization nor substrate speciﬁcities are known.
6. P4 ATPases in mammalian cells
The mammalian P4 ATPase subfamily consists of 14 proteins
(excluding alternative splice variants) which all have orthologs in
mice [12,17–19]). P4 ATPases are expressed in many different tis-
sues, including various parts of the central nervous system
([17,56], and see e.g. Allen Brain Atlas Resources [Internet]. Seattle
(WA): Allen Institute for Brain Science. Available from: http://
www.brain-map.org. [57]). The ﬁrst mammalian P4 ATPases that
were biochemically studied were bovine and mouse isoforms of
chromafﬁn granular-localized ATP8A1, which upon puriﬁcation
and reconstitution showed the highest activation of ATPase activity
in PS-containing micelles [58,59]. However, PS translocation by
ATP8A1 has not been demonstrated yet. In contrast to yeast P4
ATPases, the physiological and cellular functions of most mamma-
lian P4 ATPases are largely unexplored. The importance of mam-
malian P4 ATPases is, however, underscored by a severe human
liver disease caused by mutations in the P4 ATPase gene ATP8B1.
Mutations in ATP8B1 cause progressive familial intrahepatic chole-
stasis type 1 (PFIC1) and benign recurrent intrahepatic cholestasis
type 1 (BRIC1), two liver disorders which are characterized by an
impaired bile ﬂow ([60], and reviewed in [61]). PFIC1 patients de-
velop progressive, end-stage liver disease before adulthood,
whereas BRIC1 patients suffer from episodes of disease that evolve
and resolve spontaneously. ATP8B1 is expressed in apical mem-
branes of many epithelial cells, including the canalicular mem-
brane of hepatocytes [62,63]. The pathophysiological function of
ATP8B1 has been studied in Atp8b1-mutant mice in which a severe
PFIC1 patient mutation, resulting in a glycine to valine substitution
at position 308 (G308V), was introduced ([64] and reviewed in
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likely due to the inability of the G308V to exit the ER [65,66].
ATP8B1-deﬁcient canalicular membranes were prone to damage
induced by detergent bile salts present in the canalicular lumen,
evidenced by enhanced biliary output of canalicular ectoenzymes
(alkaline phosphatase, Cd13), cholesterol, and PS [67,68]. The
appearance of PS in bile suggests exposure of PS in the exoplasmic
leaﬂet from which it is extracted by bile salts; Hence, this indi-
rectly implies a role for ATP8B1 as a PS ﬂippase. Enhanced choles-
terol extraction from these membranes reduced the cholesterol to
PC ratio >50% which in turn impaired the activity of several trans-
porter proteins essential in bile formation [67,69]. From these
observations it has been hypothesized that ATP8B1 is essential in
the protection of the canalicular membrane to the solubilizing
capacity of bile salts [69,70]. One of the protective mechanisms
of this membrane, which is enriched in sphingolipids en choles-
terol, is to maintain a rigid, liquid-ordered, state (reviewed in
[71]). ATP8B1 maintains the asymmetric distribution of PS, which
guarantees a liquid-ordered, detergent-resistant membrane.
Similar to many PFIC1 patients, ATP8B1-deﬁcient mice suffer
from hearing loss [44]. ATP8B1 is expressed in the apical region
of the stereocilia of the cochlear hair cells in the Organ of Corti,
in which (sound) pressure-induced ﬂuid movements are converted
into action potentials. Action potentials are generated by the acti-
vation of several ion channels in these stereocilia. ATP8B1 deﬁ-
ciency leads to a progressive degeneration of stereocilia and hair
cells, thus affecting mechanotransduction. This phenotype closely
resembles the hair cell degeneration induced by neomycin, which
coincides with PS exposure (see above) [42]. From this it may be
inferred that ATP8B1 deﬁciency in the apical membrane of hair
cells leads to phospholipid scrambling (PS exposure), which causes
progressive hair cell degeneration and subsequent hearing loss.
These observations suggest an essential function for ATP8B1 in
preserving a stable membrane environment, most likely by main-
taining the asymmetric distribution of phospholipids. Indeed,
ATP8B1 overexpressed in CHO cells catalyzes enhanced plasma
membrane ﬂipping of NBD-PS and, more importantly, of natural
PS [69,72]. Still, the cell physiological functions of ATP8B1 are
poorly understood. For instance, it is not known whether ATP8B1
is a plasma membrane PS ﬂippase that is directly involved in the
maintenance of the asymmetric distribution of PS, or whether its
activity is required for the generation of endocytic transport vesi-
cles. In the latter case, ATP8B1 deﬁciency in hepatocytes would re-
sult in impaired (compensatory) endocytosis at the canalicular
membrane, which may lead to canalicular membrane expansion
and instabilization. In bile of ATP8B1-deﬁcient humans and mice
multilamellar and multivesicular structures accumulate, which
may be shedded remnants of such an instable membrane [70,73].
Furthermore, in WIF-B9 cells, a polarized hepatoma cell line,
GFP-tagged ATP8B1 localized to the apical membrane but also to
Lamp-2-positive endosomal/lysosomal (and subapical) compart-
ments, indicative for a role of ATP8B1 in the endomembrane sys-
tem [72].
Murine ATP8B3 has several splice variants which are implicated
in sperm cell acrosome formation and capacitation [74–76]. Capac-
itation is a cascade of membrane remodelling events that occurs in
spermatozoa to prepare them for binding to and penetration of the
zona pellucida. Capacitation is associated with PS exposure in the
sperm cell head; In contrast to controls, Atp8b3 knockout sperm
cells exposed PS even before capacitation. In addition, Atp8b3
knockout sperm cells displayed impaired in vitro fertilization,
however, these mice did not have signiﬁcantly reduced litter sizes
[74]. The acrosome is a Golgi-derived organelle in the head of the
sperm cell that contains digestive enzymes. The acrosome reaction
is an exocytic event by which the sperm cell secretes a.o. hydro-
lases that digest the zona pellucida, in order to fuse with the oo-cyte. Knockdown of the ATP8B3 isoform, FetA, in a mouse
mastocytoma cell line resulted in affected GA morphology and a
defect in protein secretion from these cells [76]. Furthermore, the
authors demonstrated FetA-catalized ﬂipping of NBD-PE and PC.
Impaired P4 ATPase activity may also cause more general de-
fects in lipid metabolism. For instance, mouse atp10a has been
implicated in obesity, type 2 diabetes, and non-alcoholic fatty liver
disease [77,78]. High-fat diet feeding of ATP10A-deﬁcient mice re-
sulted in hyperglycemia and enhanced insulin levels. These mice
also showed affected expression of genes involved in insulin-stim-
ulated glucose uptake, including Glut4. Glut4 is a glucose uptake
transporter in myocytes and adipocytes. Upon activation of the
insulin signalling pathway by insulin-receptor binding, Glut4 is
translocated to the membrane where it mediates the uptake of glu-
cose. The authors suggested that plasma membrane mobilization
of Glut4-containing vesicles was affected in ATP10A deﬁcient ani-
mals, however, this remains to be demonstrated. ATP10D has also
been implicated in lipid metabolism. Of 15 inbred mouse strains
only C57BL/6J contained a premature stop codon in the Atp10d
gene [79]. Interestingly, C57BL/6J mice are predisposed to develop
obesity, hyperglycemia, hyperinsulinemia, and hypertension when
fed a high-fat diet [80]. However, the relation between these phe-
notypes and ATP10D deﬁciency is not known.
Recently, a signiﬁcant association between the locus containing
the ATP8B4 gene with Alzheimer’s disease has been reported [81].
One of the SNPs described localized very close to the ATP8B4 gene
on chromosome 15. This allows the hypothesis that mutations in
ATP8B4, which is highly expressed in the brain, might play a role
in Alzheimer’s disease. However, this association remains to be
replicated.
Very recently, the close homolog of ATP8A1, ATP8A2 has been
biochemically characterized [82]. ATP8A2 is expressed in the retina
and testis of mice. In the retina, the protein localizes to the disc
membranes of the outer segments of the photoreceptor. The ATP-
ase activity of afﬁnity-puriﬁed ATP8A2 was stimulated by PS and
PE. Reconstitution of the protein into NBD-labeled phospholipid-
containing liposomes demonstrated ﬂippase activity of the protein
which was speciﬁc for NBD-PS. The authors conclude a role for
ATP8A2 in the maintenance of PS asymmetry in the disc mem-
branes of the photoreceptor. What the function of this protein is
in the testis and whether ATP8A2 deﬁciency contributes to human
disease is not known.7. The Cdc50 protein family; b-subunits or chaperones for P4
ATPases?
P4 ATPases physically interact with members of the evolution-
ary conserved CDC50 protein family, present in a.o. yeast [83],
plants [47], mammals [84], and Leishmania [85] (Fig. 2). CDC50
proteins are glycosylated 50–60-kDa proteins with two putative
transmembrane domains and a large loop that protrudes into the
exoplasmic space [83,86]. It is at present not clear whether
CDC50 proteins function as b-subunits or as chaperones for P4
ATPases. In case of a b-subunit a stable, permanent interaction oc-
curs whereas a chaperone only interacts transiently with the a-
subunit during protein maturation and trafﬁcking. CDC50 proteins
structurally resemble the b- and c-subunits of the Na,K-ATPase,
which contribute to protein maturation, trafﬁcking, and catalytic
activity [46,87]. A physical P4 ATPase-CDC50 protein interaction
is pivotal for exit of both proteins from the ER [49,72,88]. Such a
mechanism is highly reminiscent of that for non-phospholipid
translocating human P-type ATPases, including the Na,K- and
H,K-ATPase [89]. Assembly of the a- and b-subunit of these pumps
in the ER is essential for a-subunit maturation, ER exit, and modu-
lation of protein activity [90,91]. Protein sorting signals are present
Fig. 2. Phylogenetic analyses of the CDC50 protein family of mammalian, Arabid-
opsis thaliana, S. cerevisiae, and C. elegans using ClustalW sequence alignment
software (http://align.genome.jp/clustalw/). Putative CDC50 sequences from C.
elegans are derived from the C. elegans protein database Wormpep based on
sequence comparisons with all other CDC50 sequences (http://www.sanger.ac.uk/
Projects/C_elegans/WORMBASE/current/wormpep.shtml). Database accession
numbers: CDC50A (361 aa; Q9NV96), CDC50B (351 aa; Q3MIR4), CDC50C (373
aa; EAW79828 (non-reviewed sequence)), ALIS1 (350 aa; Q9LTW0), ALIS2 (343 aa;
Q67YS6), ALIS3 (349 aa; Q9SLK2), ALIS4 (353 aa; Q9SA35), ALIS5 (350 aa; Q8L8W0),
Lem3p (414 aa; P42838), Cdc50p (391 aa; P25656), Crf1p (393 aa; P53740), C.
elegans Cdc50p1 (348 aa; Q21844), C. elegans Cdc50p2 (361 aa; Q19635), C. elegans
Cdc50p3 (352 aa; Q23151).
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Na,K-ATPase localizes to the basolateral membrane [94]. Three
Na,K-ATPase b-subunits have been identiﬁed, b1–b3, of which b1
and b3 are associated with basolateral localization of the a-subunit
[90,91]. However, a-subunits associated with a b2-subunit localize
to the apical membrane, as is the case in retinal pigment epithe-
lium [95], prostate gland secretory epithelium [96], in the choroid
plexus [97], and in polycystic kidney disease which is associated
with aberrant expression of the b2-subunit [98]. This unusual local-
ization is due to the glycosylation status of the b2-subunit [99]; The
Na,K-ATPase b2-subunit structurally resembles the H,K-ATPase b-
subunit (the H,K-ATPase localizes to the apical membrane), in that
they both have up till 9 N-glycosylation sites while b1 and b3 only
have 3 N-glycosylation sites. This suggests an important function
for the b-subunit in sorting of the protein complex. Although it is
clear that a CDC50 protein-P4 ATPase physical interaction is piv-
otal for release of the P4 ATPase from the ER, the contribution of
CDC50 proteins to subcellular trafﬁcking, catalytic activity, and/
or substrate speciﬁcity of the P4 ATPase is not clear.
The CDC50 protein family of yeast has ﬁrst been described by
Kato et al. [83]. Genetic studies suggested a strong correlation be-
tween P4 ATPases and CDC50 proteins, in that these mutant cells
displayed similar phenotypes [21,22,36,83,100]. Saito et al. [88]
were the ﬁrst to demonstrate that CDC50 proteins were accessory
proteins for P4 ATPases. Drs2p assembles with Cdc50p, while
Dnf1p and Dnf2p assemble with Lem3p. A third homolog, Crf1p
assembles with Dnf3p whereas Neo1p doesn’t interact with nei-
ther of the three CDC50 homologs. These interactions are speciﬁc
as shown by immunoprecipitation and split-ubiquitin assays
[24,29,88,101].
In contrast to yeast CDC50 proteins, CDC50 proteins in Arabid-
opsis, termed ALIS proteins (for ALA-interacting subunit), did not
display a speciﬁc preference for an ALA P4 ATPase. In Arabidopsis,
ﬁve ALIS proteins (1–5) are expressed, of which ALIS1 is the most
likely physiological binding partner of ALA3 [47]. Lopez-Marqueset al. [49] studied the physiological functionality, subcellular local-
ization, and substrate speciﬁcities of two P4 ATPases, ALA2 and
ALA3, upon co-expression with 3 out of 5 ALIS proteins in Drs2p/
Dnf1p/Dnf2p triple mutant yeast cells. When expressed in this tri-
ple mutant, both the ALA and ALIS proteins were released from the
ER only upon co-expression. Independent of which ALIS protein
was co-expressed with ALA2 (subcellular localization: prevacuolar
compartment) or ALA3 (subcellular localization: GA), both P4 ATP-
ases always displayed the same physiological functionality, sub-
strate speciﬁcity, and subcellular localization. Instead, the P4
ATPases determined the subcellular localization of the different
ALIS proteins. These observations indicate that the ALIS proteins
do not determine the subcellular localization nor determine the
substrate speciﬁcities of the P4 ATPase.
Studies in non-polarized mammalian cells do suggest a role for
CDC50 proteins in subcellular trafﬁcking of ATP8B1. In mammals,
three CDC50 proteins are expressed (excluding alternative splice
variants), and are termed CDC50A–C [12,18,84]. Co-expression of
ATP8B1 with CDC50A or CDC50B in Chinese hamster ovary cells al-
lowed exit of both proteins from the ER and trafﬁcking to the plas-
ma membrane and endosomal/lysosomal compartments,
respectively [72], Folmer et al., manuscript in preparation). Similar
to the b-subunits of the Na,K-ATPase [99], the N-glycosylation sta-
tus of CDC50A (four N-glycosylation sites) and CDC50B (six N-gly-
cosylation sites) may determine subcellular trafﬁcking of P4
ATPases; however, targeting may be determined by the P4 ATPase
itself and/or by other P4 ATPase-CDC50 interacting proteins. We
anticipate that the three CDC50 proteins serve as accessory pro-
teins for many, if not all, P4 ATPases. CDC50A and CDC50B are
ubiquitously expressed while CDC50C is mainly expressed in testis
and brain ([84,102,103] and see Allen Brain Atlas Resources avail-
able from: http://www.brain-map.org. [57]). The speciﬁcity of
CDC50–P4 ATPase interactions is presently not known, although,
based on overlapping expression proﬁles, it has been hypothesized
that ATP8B3 and CDC50C and ATP8B1 and CDC50A are physiolog-
ically relevant binding partners [19,72,74,75,103].
For C. elegans no interactions with CDC50 proteins have been
described yet. The C. elegans genome encodes at least three se-
quences with considerable homology to known members of the
CDC50 protein family (Fig. 2).
One important question is whether CDC50 proteins are involved
in the modulation of P4 ATPase activity. Thus far, no conclusive
evidence has been presented that rejects this assumption. First,
reconstituted, N-terminal-tagged Drs2p (but not of C-terminal
tagged Drs2p) catalyzed the ﬂipping of NBD-PS in proteoliposomes
([35]. However, in the Drs2p preparations additional proteins were
present, including Cdc50p, which is consistent with a role for stim-
ulating Drs2p-mediated ﬂippase activity. Secondly, Lenoir et al.
[104] presented data that Cdc50p is required in the reaction cycle
of Drs2p; Cdc50p, but not Lem3p, stimulated Drs2p phosphoen-
zyme formation; In addition, the afﬁnity of Cdc50p for Drs2p ﬂuc-
tuated, but was the highest during loading of the phospholipid
substrate. Thirdly, the reconstituted ATP8A2 preparations (which
catalyzed NBD-PS ﬂipping) may have been contaminated with
CDC50A [82], which is expressed in outer segments of the photore-
ceptor [105].8. How do P4 ATPases drive vesiculation?
From the studies in yeast it is evident that P4 ATPases are piv-
otal in the formation of transport vesicles by ﬂipping phospholip-
ids from the exoplasmic to the cytosolic face of the bilayer. How
does this process drive vesicle formation? The current models are
based on the bilayer couple hypothesis [106]. The bilayer couple
hypothesis proposes that if one leaﬂet of the bilayer expands e.g.
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the coupled leaﬂet follows, which leads to bending of the bilayer.
The resulting membrane curvature can be the initiating event in
the generation of vesicles. Farge et al. [107] have shown that the
formation of endocytic vesicles could be enhanced when the cyto-
solic leaﬂet surface area was increased upon administration of PS
and PE but not by lyso-alpha-phosphatidylserine (PS and PE were
ﬂipped into the cytosolic leaﬂet by a plasma membrane ﬂippase,
whereas lyso-alpha-phosphatidylserine was not a substrate for this
plasma membrane ﬂippase).
A bilayer couple hypothesis-based model is applicable for Drs2p-
catalyzed clathrin-coated vesicle formation [86,108]. Drs2p medi-
ates the translocation of phospholipids from the exoplasmic- to
the cytosolic face of the TGN (or endosome), which results in a po-
sitive curvature of the membrane i.e. bending of the membrane to-
wards the cytosol. In this way, Drs2p facilitates coat protein
binding and mobilization of the vesicle-generating protein
machinery. Similarly, Dnf1p and Dnf2p may be important for gen-
erating initial positive membrane curvature at the plasma mem-
brane, thus facilitating coat protein binding and mobilization of
the endocytic protein machinery. Alternatively, Dnf1p/Dnf2p may
redistribute/concentrate speciﬁc phospholipid species, which trig-
gers mobilization or release of the protein budding/ﬁssion machin-
ery. The latter model is supported by ﬁndings in Lem3p mutant
cells, which have a delayed apical-isotropic growth switch at the
growing bud tip [109]. The apical-isotropic growth switch is trig-
gered by the release of Cdc42p from the membrane after activation
of its GTPase activity by the GTPase activating proteins (GAPs)
Rga1p/2p. Rga1p/2p are activated by PS and PE [109]. During early
budding stages, PE is locally concentrated in the exoplasmic leaﬂet
at the apical growth site; In the corresponding cytosolic leaﬂet,
Cdc42p is concentrated. The authors propose that Dnf1p- or
Dnf2p-Lem3p-mediated PE ﬂipping to the cytosolic leaﬂet acti-
vates GAP-mediated release of Cdc42p, which triggers the growth
switch. However, also in this case, enhanced phospholipid concen-
tration in the cytosolic leaﬂet can drive vesiculation and, as a con-
sequence, release of Cdc42p via endocytosis.9. Conclusions
From all the published work it is clear that P4 ATPases serve
important functions in cellular physiology. First, P4 ATPases are
critical initiating determinants of the vesicle-generating machinery
and thus of polarized membrane and protein transport. Secondly,
P4 ATPases are, either directly or indirectly, important in maintain-
ing an optimal physical state of the (plasma) membrane, which is
essential for proper membrane barrier- and membrane protein
function.
In yeast, all ﬁve P4 ATPases are important in the biogenesis of
transport vesicles in several intracellular vesicular transport
routes. Also in plants and worms, there is emerging evidence for
a role of P4 ATPase in the generation of transport vesicles. In mam-
malian cells, however, still very little is known about the roles of P4
ATPases in cellular physiology. When extrapolating the ﬁndings in
yeast, plants and worms, mammalian P4 ATPases may also be
implicated in the initiation of vesiculation. A role for mammalian
P4 ATPases in vesicle biogenesis along different trafﬁcking path-
ways would be especially relevant for epithelial cells and neuronal
cells. In epithelial cells, for instance hepatocytes and enterocytes,
major endocytic, exocytic, and transcytotic transport routes need
to be maintained in order to efﬁciently facilitate excretion, uptake,
and/or recycling of numerous substrates. In neuronal cells, exten-
sive and rapid anterograde and retrograde vesicular transport is
essential for proper signal propagation. For instance, newly synthe-
sized neurotransmitters need to be transported from the cell bodyto the axon terminal, released into the synaptic cleft, and cleared
from the synaptic cleft by endocytosis (or breakdown). Many P4
ATPases are abundantly expressed in the brain (See Allen Brain At-
las Resources available from: http://www.brain-map.org., and
[17]). Also in liver and in the human hepatoma cell line HepG2,
many P4 ATPases are expressed ([17], our unpublished results).
How all these different proteins contribute to cellular homeostasis
is not known. Impairment of functional cellular polarity e.g. by
mutations in P4 ATPase genes may cause severe and complex hu-
man inherited diseases. One example of complex disease is associ-
ated with mutations in ATP8B1. Despite the severe liver phenotype,
patients also suffer from other less severe phenotypes, including
hearing loss, diarrhea, or abnormal sweat electrolyte concentra-
tions. At present, however, it remains to be elucidated how ATP8B1
deﬁciency results in these different phenotypes. Although it is clear
that ATP8B1 deﬁciency interferes with normal membrane function,
a primary role in the vesicle-generating machinery cannot be ex-
cluded. It is a major challenge to elucidate the contribution of
mammalian P4 ATPases in maintaining cellular homeostasis and
to elucidate how P4 ATPase deﬁciencies contribute to human
inherited diseases, such as ATP8B1 disease.
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